High panel reactive antibody against cross-reactive group antigens as a contraindication to renal allotransplantation

Experimental and Molecular Pathology

Volumn 71, Issue 1, 2001, Pages 73-78

  Dilioglou, Smaroula ^a   Cruse, Julius M ^a   Lewis, Robert E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CROSS REACTION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE;

EID: 0034868475     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.2001.2356     Document Type: Article

References (7)

1. Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies
2. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells
3. A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: A single-center study of first cadaveric kidneys to nonsensitized recipients
4. Public epitopes and the antigenic structure of the HLA molecules
5. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients